mental health - Nursing Case Study
Pathophysiology
• Primary mechanism: Neurotransmitter imbalances - Mental health disorders often arise from imbalances in neurotransmitters such as serotonin, dopamine, and norepinephrine, crucial for mood regulation, thought processes, and emotions. Imbalances can result from genetic predispositions, environmental factors, and stress.
• Secondary mechanism: Neuroplasticity alterations - Changes in brain structure and function, known as neuroplasticity, can be impacted by prolonged stress or trauma. This can lead to maladaptive neural connections, affecting cognition and emotion processing.
• Key complication: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis - Chronic stress can dysregulate the HPA axis, leading to excessive cortisol production, which further exacerbates neurotransmitter imbalances and neuroplasticity alterations, perpetuating mental health symptoms.
Patient Profile
Demographics:
32-year-old female, software engineer
History:
• Key past medical history: Generalized Anxiety Disorder, Depression
• Current medications: Sertraline 50 mg daily, Lorazepam 0.5 mg as needed
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing anxiety and difficulty concentrating
• Key symptoms: Persistent worry, sleep disturbances, episodes of heart palpitations
• Vital signs: Blood Pressure 142/88 mmHg, Heart Rate 98 bpm, Respiratory Rate 20 breaths/min, Temperature 98.7°F
Section 1
During a follow-up visit, the patient reports that her anxiety symptoms have intensified over the past two weeks, despite adherence to her current medication regimen. She describes experiencing more frequent heart palpitations and a persistent sense of dread that disrupts her daily functioning, particularly at work. She notes that her difficulty concentrating has affected her performance as a software engineer, leading to increased stress and worry about her job security. A mental status examination reveals an anxious affect and difficulty maintaining focus during the interview. Her vital signs show a blood pressure of 148/92 mmHg and a heart rate of 102 bpm, indicating a potential worsening of her stress response.
Recognizing the need for further investigation, the healthcare team orders a set of diagnostic tests, including a complete blood count (CBC), thyroid function tests, and serum cortisol levels. The results indicate mildly elevated cortisol levels, suggesting hyperactivity of the HPA axis. Thyroid function tests are within normal limits, ruling out thyroid dysfunction as a contributing factor. The elevated cortisol levels align with the patient's chronic stress and anxiety issues, reinforcing the hypothesis that dysregulation of the HPA axis is exacerbating her symptoms.
Given these findings, the clinical team considers adjusting her treatment plan. A discussion is initiated about potential modifications to her medication regimen, such as increasing the dose of sertraline or adding a different anxiolytic to better manage her symptoms. Additionally, the team explores non-pharmacological interventions, including cognitive-behavioral therapy (CBT) and mindfulness-based stress reduction techniques, to address the neuroplasticity alterations and support the patient in developing healthier coping mechanisms. The patient agrees to the proposed plan, hopeful that these changes will alleviate her symptoms and improve her quality of life. This decision sets the stage for monitoring her response to the new interventions and evaluating their effectiveness in her ongoing care.
Section 2
Several weeks after implementing the revised treatment plan, the patient returns for a follow-up appointment. During this visit, she reports a modest improvement in her anxiety symptoms, attributing some relief to the addition of cognitive-behavioral therapy sessions. She has been able to incorporate mindfulness exercises into her daily routine, which she finds helpful in managing acute episodes of anxiety. However, she continues to experience intermittent heart palpitations and a lingering sense of dread, especially during high-stress situations at work. Her concentration, while slightly improved, remains inconsistent, impacting her productivity as a software engineer.
A repeat mental status examination reveals a slightly more relaxed affect, but moments of distractibility are still apparent. Her vital signs show some improvement, with a blood pressure of 140/88 mmHg and a heart rate of 96 bpm. These changes suggest a partial response to treatment but indicate that her stress response has not fully normalized. The clinical team decides to further evaluate the patient's progress by ordering a follow-up serum cortisol level. The results show that cortisol levels remain elevated, albeit slightly lower than at the previous assessment. This finding suggests that while there has been some amelioration of HPA axis hyperactivity, the underlying dysregulation persists.
Given the partial response to the current interventions, the healthcare team deliberates the next steps. They consider increasing the sertraline dosage further and continuing the anxiolytic, while also emphasizing the importance of sustained engagement in psychotherapy. The team also discusses the potential benefit of exploring additional therapeutic modalities, such as biofeedback or yoga, to enhance stress resilience. The patient expresses willingness to continue with the refined treatment plan, acknowledging the progress made and remaining hopeful for further improvement. The team plans for regular follow-up visits to closely monitor her physiological and psychological status, ensuring timely adjustments to her care as needed.
Section 3
Several weeks later, the patient returns for another follow-up appointment, reporting mixed progress. While she continues to engage in cognitive-behavioral therapy and mindfulness practices, she has started experiencing new symptoms that are concerning. In addition to the ongoing heart palpitations and occasional sense of dread, she now reports experiencing fatigue, muscle tension, and frequent headaches. These symptoms have become more pronounced, particularly during the late afternoon, and have begun to affect her sleep quality, resulting in increased daytime sleepiness and irritability.
During the clinical assessment, her vital signs reveal a blood pressure of 148/92 mmHg and a heart rate of 100 bpm, indicating a slight increase in both parameters since the last visit. The mental status examination notes an anxious affect and increased distractibility, with moments of rumination during the interview. Concerned about the possibility of somatic symptom exacerbation or another underlying condition contributing to her stress response, the healthcare team decides to conduct a comprehensive metabolic panel and thyroid function tests to rule out physiological contributors to her current state.
The results reveal that her thyroid-stimulating hormone (TSH) level is elevated at 5.5 mIU/L, suggesting the presence of subclinical hypothyroidism, which may be contributing to her fatigue and mood symptoms. The team deliberates on the implications of these findings and considers the potential benefits of initiating levothyroxine therapy to address her thyroid dysfunction, alongside her current treatment regimen. Meanwhile, further education on stress management and lifestyle modification is reinforced, with the suggestion to incorporate yoga as an adjunctive therapy. The patient is receptive to these recommendations, hopeful that addressing the thyroid issue might alleviate some of her symptoms, and agrees to follow up in four weeks to reassess her condition and response to the new intervention.
Section 4
Four weeks later, the patient returns for her follow-up appointment. She reports some improvement in her energy levels since starting levothyroxine, though she still experiences intermittent fatigue and muscle tension. Her headaches have decreased in frequency, but her sleep quality remains disrupted. During the clinical assessment, her vital signs reveal a blood pressure of 140/88 mmHg and a heart rate of 92 bpm, showing a slight improvement. However, the mental status examination highlights persistent anxiety, with periods of heightened irritability and difficulty concentrating. The patient mentions occasional episodes of vivid dreams and waking up with a racing heart, which have started to cause her distress.
Given these developments, the healthcare team considers the possibility of an anxiety disorder with a component of sleep disturbance that may not be fully addressed by the current treatment plan. To further explore her sleep issues, they recommend a sleep study to evaluate for any underlying sleep disorders, such as sleep apnea or periodic limb movement disorder, which could be contributing to her daytime symptoms. Additionally, they decide to adjust her cognitive-behavioral therapy sessions to focus more intensively on anxiety management techniques, particularly targeting her rumination and nighttime anxiety.
The patient expresses concern over the potential need for additional diagnostic procedures but acknowledges the importance of understanding the full scope of her symptoms. She agrees to proceed with the sleep study and commits to the adjusted therapy focus. The team reassures her of the collaborative approach to her care, emphasizing the goal of achieving a more comprehensive understanding of her condition and optimizing her treatment regimen. The patient is scheduled for another follow-up in six weeks to review the sleep study results and assess her response to these new interventions.
Section 5
Six weeks later, the patient returns for her follow-up appointment with the healthcare team, armed with the results of her recent sleep study. The study reveals the presence of mild obstructive sleep apnea and periodic limb movement disorder, both of which could be contributing to her disrupted sleep patterns and subsequent daytime fatigue. Her vital signs remain relatively stable, with a blood pressure of 138/86 mmHg and a heart rate of 88 bpm, though she notes a persistent sense of restlessness.
In discussing the findings, the team explains how these sleep disturbances could be exacerbating her anxiety symptoms and impacting her overall mental health. They propose incorporating a CPAP (Continuous Positive Airway Pressure) machine to manage her sleep apnea and suggest specific lifestyle modifications to address her limb movements during sleep. Additionally, they emphasize the importance of continuing her adjusted cognitive-behavioral therapy, which has shown promise in helping her manage anxiety more effectively through targeted techniques like mindfulness and scheduled worry time.
The patient appears relieved to have a clearer understanding of her condition and expresses a willingness to integrate these new interventions into her routine. She acknowledges the interconnectedness of her physical and mental health symptoms and is motivated to adhere to the treatment plan. The healthcare team schedules another follow-up in six weeks to evaluate her adaptation to the CPAP therapy, assess any improvements in her sleep quality, and monitor her anxiety levels. They also plan to re-evaluate her medication regimen to ensure it aligns with her evolving needs.